Viatris Wins FDA Approval for RYZUMVI to Treat Presbyopia
Viatris has received approval from the U.S. Food and Drug Administration (FDA) for RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults. The approval expands…
Read More...
Read More...
